{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T11:25:19Z","timestamp":1763810719709,"version":"build-2065373602"},"reference-count":49,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003347","name":"Fudan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFC1312900"],"award-info":[{"award-number":["2018YFC1312900"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jval.2021.10.014","type":"journal-article","created":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T17:31:06Z","timestamp":1639416666000},"page":"975-983","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Long-Term Cost-Effectiveness Comparison of Catheter Ablation and Antiarrhythmic Drugs in Atrial Fibrillation Treatment Using Discrete Event Simulation"],"prefix":"10.1016","volume":"25","author":[{"given":"Min","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wangyang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jval.2021.10.014_bib1","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/europace\/eux274","article-title":"2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"20","author":"Calkins","year":"2018","journal-title":"Europace"},{"issue":"8","key":"10.1016\/j.jval.2021.10.014_bib2","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.jval.2021.10.014_bib3","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.amjcard.2018.05.015","article-title":"The disease Burden of atrial fibrillation in China from a national cross-sectional survey","volume":"122","author":"Wang","year":"2018","journal-title":"Am J Cardiol"},{"issue":"8","key":"10.1016\/j.jval.2021.10.014_bib4","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.jval.2021.10.014_bib5","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/archinte.1995.00430050045005","article-title":"Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications","volume":"155","author":"Feinberg","year":"1995","journal-title":"Arch Intern Med"},{"issue":"18","key":"10.1016\/j.jval.2021.10.014_bib6","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in atrial fibrillation (ATRIA) Study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.jval.2021.10.014_bib7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0167-5273(01)00626-X","article-title":"Trends in case-fatality in 22968 patients admitted for the first time with atrial fibrillation in Scotland, 1986-1995","volume":"82","author":"Stewart","year":"2002","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jval.2021.10.014_bib8","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.jval.2021.10.014_bib9","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","volume":"140","author":"January","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jval.2021.10.014_bib10","first-page":"315","article-title":"Atrial fibrillation: current understanding and treatment Recommendations-2018","volume":"32","author":"Huang","year":"2018","journal-title":"Chin J Card Pacing Electrophysiol"},{"issue":"5","key":"10.1016\/j.jval.2021.10.014_bib11","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/europace\/eut380","article-title":"Cost-effectiveness of cryoballoon ablation for the management of paroxysmal atrial fibrillation","volume":"16","author":"Reynolds","year":"2014","journal-title":"Europace"},{"issue":"6","key":"10.1016\/j.jval.2021.10.014_bib12","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s40256-019-00349-1","article-title":"A\u00a0long-term cost-effectiveness analysis comparing radiofrequency catheter ablation with antiarrhythmic drugs in treatment of Chinese patients with atrial fibrillation","volume":"19","author":"Du","year":"2019","journal-title":"Am J Cardiovasc Drugs"},{"issue":"7","key":"10.1016\/j.jval.2021.10.014_bib13","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/hrt.2008.147165","article-title":"Cost-effectiveness of radiofrequency catheter ablation for the treatment of atrial fibrillation in the United Kingdom","volume":"95","author":"McKenna","year":"2009","journal-title":"Heart"},{"issue":"8","key":"10.1016\/j.jval.2021.10.014_bib14","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.jval.2019.02.001","article-title":"Cost-effectiveness of cryoballoon ablation versus radiofrequency ablation for paroxysmal atrial fibrillation in China: results based on real-world data","volume":"22","author":"Ming","year":"2019","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.jval.2021.10.014_bib15","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.clinthera.2018.11.008","article-title":"Radiofrequency catheter ablation versus cryoballoon ablation in the treatment of paroxysmal atrial fibrillation: A cost-effectiveness analysis in China","volume":"41","author":"Sun","year":"2019","journal-title":"Clin Ther"},{"issue":"3","key":"10.1016\/j.jval.2021.10.014_bib16","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/europace\/euaa298","article-title":"Catheter ablation or medical therapy to delay progression of atrial fibrillation: the randomized controlled atrial fibrillation progression trial (ATTEST)","volume":"23","author":"Kuck","year":"2021","journal-title":"Europace"},{"issue":"58","key":"10.1016\/j.jval.2021.10.014_bib17","doi-asserted-by":"crossref","DOI":"10.3310\/hta17580","article-title":"Economic modelling of diagnostic and treatment pathways in National Institute for Health and Care Excellence clinical guidelines: the Modelling Algorithm Pathways in Guidelines (MAPGuide) project","volume":"17","author":"Lord","year":"2013","journal-title":"Health Technol Assess"},{"issue":"5","key":"10.1016\/j.jval.2021.10.014_bib18","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1177\/0272989X12455462","article-title":"Modeling using discrete event simulation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-4","volume":"32","author":"Karnon","year":"2012","journal-title":"Med Decis Mak"},{"issue":"4","key":"10.1016\/j.jval.2021.10.014_bib19","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2165\/00019053-200523040-00003","article-title":"Pharmacoeconomic analyses using discrete event simulation","volume":"23","author":"Caro","year":"2005","journal-title":"Pharmacoeconomics"},{"year":"2006","series-title":"Decision Modelling for Health Economic Evaluation","author":"Briggs","key":"10.1016\/j.jval.2021.10.014_bib20"},{"author":"Liu","key":"10.1016\/j.jval.2021.10.014_bib21"},{"issue":"14","key":"10.1016\/j.jval.2021.10.014_bib22","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1177\/2047487317715769","article-title":"Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: a systematic review and meta-analysis","volume":"24","author":"Ruddox","year":"2017","journal-title":"Eur J Prev Cardiol"},{"issue":"4","key":"10.1016\/j.jval.2021.10.014_bib23","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1524-4733.2008.00476_1.x","article-title":"Economic evaluation for devices and drugs--same or different?","volume":"12","author":"Drummond","year":"2009","journal-title":"Value Health"},{"issue":"2","key":"10.1016\/j.jval.2021.10.014_bib24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2217\/cer-2019-0165","article-title":"Comparative effectiveness of catheter ablation devices in the treatment of atrial fibrillation: a network meta-analysis","volume":"9","author":"Gupta","year":"2020","journal-title":"J\u00a0Comp Eff Res"},{"issue":"12","key":"10.1016\/j.jval.2021.10.014_bib25","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/eurheartj\/ehr488","article-title":"Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish atrial fibrillation cohort study","volume":"33","author":"Friberg","year":"2012","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.jval.2021.10.014_bib26","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1001\/archinte.165.10.1185","article-title":"Occurrence and characteristics of stroke events in the atrial fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study","volume":"165","author":"Sherman","year":"2005","journal-title":"Arch Intern Med"},{"issue":"21","key":"10.1016\/j.jval.2021.10.014_bib27","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1136\/hrt.2008.150177","article-title":"Epidemiology and clinical management of cardiomyopathies and heart failure in China","volume":"95","author":"Jiang","year":"2009","journal-title":"Heart"},{"issue":"8","key":"10.1016\/j.jval.2021.10.014_bib28","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.hrthm.2014.04.021","article-title":"Risk of stroke and intracranial hemorrhage in 9727 Chinese with atrial fibrillation in Hong Kong","volume":"11","author":"Siu","year":"2014","journal-title":"Heart Rhythm"},{"issue":"3","key":"10.1016\/j.jval.2021.10.014_bib29","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0735-1097(98)00297-6","volume":"32","author":"Dries","year":"1998","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jval.2021.10.014_bib30","first-page":"1004","article-title":"Analysis on application of oral anticoagulants in atrial fibrillation disease in seven cities in China from 2014 to 2018","volume":"35","author":"Guo","year":"2020","journal-title":"Drugs Clin"},{"key":"10.1016\/j.jval.2021.10.014_bib31","first-page":"191","article-title":"Clinical effects and costs of three different anticoagulation modes in patients with atrial fibrillation catheter ablation","volume":"36","author":"Zhao","year":"2018","journal-title":"J\u00a0Prev Chin PLA"},{"article-title":"National Institute for Health and Clinical Excellence guidance","year":"2006","series-title":"Atrial Fibrillation: National Clinical Guideline for Management in Primary and Secondary Care","key":"10.1016\/j.jval.2021.10.014_bib33"},{"article-title":"NICE process and methods guides","year":"2013","series-title":"Guide to the Methods of Technology Appraisal 2013","key":"10.1016\/j.jval.2021.10.014_bib34"},{"issue":"9","key":"10.1016\/j.jval.2021.10.014_bib35","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1161\/01.CIR.0000157153.30978.67","article-title":"Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation","volume":"111","author":"Cappato","year":"2005","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jval.2021.10.014_bib36","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11136-010-9762-x","article-title":"Population health status in China: EQ-5D results, by age, sex and socio-economic status, from the National Health Services survey 2008","volume":"20","author":"Sun","year":"2011","journal-title":"Qual Life Res"},{"issue":"4","key":"10.1016\/j.jval.2021.10.014_bib37","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1524-4733.2008.00494.x","article-title":"An economic evaluation of valsartan for post-MI patients in the UK who are not suitable for treatment with ACE inhibitors","volume":"12","author":"Taylor","year":"2009","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2021.10.014_bib38","first-page":"175","article-title":"Cost-effectiveness of amlodipine compared with valsartan in preventing stroke and myocardial infarction among hypertensive patients in Taiwan","volume":"9","author":"Chan","year":"2016","journal-title":"Int J Gen Med"},{"issue":"9","key":"10.1016\/j.jval.2021.10.014_bib39","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1007\/s12325-016-0375-9","article-title":"A\u00a0cost-effectiveness analysis of clopidogrel for patients with non-ST-segment elevation acute coronary syndrome in China","volume":"33","author":"Cui","year":"2016","journal-title":"Adv Ther"},{"issue":"10","key":"10.1016\/j.jval.2021.10.014_bib40","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/jce.13047","article-title":"Cryoballoon versus radiofrequency catheter ablation in atrial fibrillation: a meta-analysis","volume":"27","author":"Cardoso","year":"2016","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"issue":"23","key":"10.1016\/j.jval.2021.10.014_bib41","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMoa1602014","article-title":"Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation","volume":"374","author":"Kuck","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.jval.2021.10.014_bib42","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.jval.2021.10.014_bib43","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.jval.2021.10.014_bib44","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.clinthera.2019.11.011","article-title":"Cost-effectiveness of dabigatran compared with Rivaroxaban for prevention of stroke and systemic embolism in patients with atrial fibrillation in China","volume":"42","author":"Dong","year":"2020","journal-title":"Clin Ther"},{"key":"10.1016\/j.jval.2021.10.014_bib45","first-page":"1216","article-title":"Economic evaluation of dabigatran, Rivaroxaban and warfarin in preventing stroke in patients with atrial fibrillation","volume":"25","author":"Chen","year":"2016","journal-title":"Chin J New Drugs"},{"issue":"3","key":"10.1016\/j.jval.2021.10.014_bib46","doi-asserted-by":"crossref","first-page":"177","DOI":"10.15420\/aer.2014.3.3.177","article-title":"Evaluating the cost-effectiveness of catheter ablation of atrial fibrillation","volume":"3","author":"Chang","year":"2014","journal-title":"Arrhythm Electrophysiol Rev"},{"issue":"1","key":"10.1016\/j.jval.2021.10.014_bib47","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/europace\/euz235","article-title":"The safety of discontinuation of oral anticoagulation therapy after apparently successful atrial fibrillation ablation: a report from the Chinese Atrial Fibrillation Registry study","volume":"22","author":"Yang","year":"2020","journal-title":"Europace"},{"issue":"1","key":"10.1016\/j.jval.2021.10.014_bib48","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1540-8167.2008.01303.x","article-title":"Cost comparison of ablation versus antiarrhythmic drugs as first-line therapy for atrial fibrillation: an economic evaluation of the RAAFT pilot study","volume":"20","author":"Khaykin","year":"2009","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"issue":"2-3","key":"10.1016\/j.jval.2021.10.014_bib49","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0167-5273(02)00380-7","article-title":"Effectiveness and costs of chemical versus electrical cardioversion of atrial fibrillation","volume":"88","author":"de Paola","year":"2003","journal-title":"Int J Cardiol"},{"issue":"5","key":"10.1016\/j.jval.2021.10.014_bib50","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jacep.2016.12.015","article-title":"Cost-effectiveness and clinical effectiveness of the risk factor Management Clinic in atrial fibrillation: the CENT study","volume":"3","author":"Pathak","year":"2017","journal-title":"JACC Clin Electrophysiol"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301521031776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301521031776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:28:05Z","timestamp":1761096485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301521031776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1098301521031776"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2021.10.014","relation":{},"ISSN":["1098-3015"],"issn-type":[{"type":"print","value":"1098-3015"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Cost-Effectiveness Comparison of Catheter Ablation and Antiarrhythmic Drugs in Atrial Fibrillation Treatment Using Discrete Event Simulation","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2021.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}